π¨ New Trial Alert π¨
Can we safely stop anticoagulation after AF ablation? The ALONE-AF Trial π« suggests yesβin selected patients with no AF recurrence, stopping DOACs reduced major bleeding π without increasing stroke risk π§ .
Β
π 0.3% vs 2.2% for the composite outcome (P = .02)
π Carefully monitored, low-risk patients may benefit most.
Β
π Editorial: Recommends shared decision-making π€ & individualized rhythm monitoring.
π A potential shift in post-ablation care.
Β
π #AFib #Anticoagulation #EPTrials #CardioTwitter #StrokePrevention #JAMA #ALONEAF #Electrophysiology #SharedDecisionMaking #ClinicalTrials